![Bengt Westermark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bengt Westermark
Direttore/Membro del Consiglio presso
MEDIVIR AB
Profilo
Bengt Westermark is the founder of Mesenkia Therapeutics AB, serving as Chairman since 2023.
Current jobs include Independent Director at Medivir AB since 2017, Member of the Royal Swedish Academy of Sciences, Professor at the University of Uppsala since 2002, Member of the European Molecular Biology Organization, Member of the Royal Society of Sciences, and Member of The European Academy of Cancer Sciences.
Former jobs include Chairman-Research Board at The Swedish Cancer Society from 2003 to 2013, Independent Director at Medivir AB from 2017 to 2021, and Director at Hamlet BioPharma AB.
Posizioni attive di Bengt Westermark
| Società | Posizione | Inizio |
|---|---|---|
| MEDIVIR AB | Direttore/Membro del Consiglio | 01/01/2017 |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1986 |
Royal Swedish Academy of Sciences
 Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Provides research and development services on sciences | Corporate Officer/Principal | - |
European Molecular Biology Organization | Corporate Officer/Principal | - |
Royal Society of Sciences | Corporate Officer/Principal | - |
The European Academy of Cancer Sciences
 The European Academy of Cancer Sciences Miscellaneous Commercial ServicesCommercial Services Operates as advisory body of eminent oncologists and cancer researchers | Corporate Officer/Principal | - |
Precedenti posizioni note di Bengt Westermark
| Società | Posizione | Fine |
|---|---|---|
| MEDIVIR AB | Direttore/Membro del Consiglio | 05/05/2021 |
The Swedish Cancer Society | Corporate Officer/Principal | 01/01/2013 |
| HAMLET PHARMA AB (PUBL) | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
79
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Medivir AB
 Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Royal Swedish Academy of Sciences
Royal Swedish Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Provides research and development services on sciences | Commercial Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Swedish Cancer Society | |
European Molecular Biology Organization | |
Hamlet BioPharma AB
 Hamlet BioPharma AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products specifically for cancer patients | Health Technology |
Royal Society of Sciences | |
The European Academy of Cancer Sciences
The European Academy of Cancer Sciences Miscellaneous Commercial ServicesCommercial Services Operates as advisory body of eminent oncologists and cancer researchers | Commercial Services |
